Bactrim and Lipodystrophy acquired - a phase IV clinical study of FDA data

Summary:

Lipodystrophy acquired is reported as a side effect among people who take Bactrim (sulfamethoxazole; trimethoprim), especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years also take Kaletra, and have Hiv infection.

The phase IV clinical study analyzes which people have Lipodystrophy acquired when taking Bactrim. It is created by eHealthMe based on reports of 86,509 people who have side effects when taking Bactrim from the FDA, and is updated regularly.

What is Bactrim?

Bactrim has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 89,117 Bactrim users. Check the latest studies of Bactrim.

What is Lipodystrophy acquired?

Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired) is found to be associated with 174 drugs and 238 conditions by eHealthMe. Check the latest studies of Lipodystrophy acquired.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 20, 2026

86,509 people reported to have side effects when taking Bactrim.
Among them, 53 people (0.06%) have Lipodystrophy acquired.

Could Bactrim cause Lipodystrophy acquired?

Among these 53 people:

How long have people been on Bactrim when they have Lipodystrophy acquired? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 14.29 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 14.29 %
  • 2 - 5 years: 57.14 %
  • 5 - 10 years: 14.29 %
  • 10+ years: 0.0 %

What is the gender of people who have Lipodystrophy acquired when taking Bactrim? *

  • female: 56.6 %
  • male: 43.4 %

What is the age of people who have Lipodystrophy acquired when taking Bactrim? *

  • 0-1: 0.0 %
  • 2-9: 2.22 %
  • 10-19: 0.0 %
  • 20-29: 13.33 %
  • 30-39: 17.78 %
  • 40-49: 35.56 %
  • 50-59: 15.56 %
  • 60+: 15.56 %

What are other drugs people take besides Bactrim? *

  1. Kaletra: 24 people, 45.28%
  2. Epivir: 21 people, 39.62%
  3. Zerit: 21 people, 39.62%
  4. Videx: 17 people, 32.08%
  5. Ziagen: 15 people, 28.30%
  6. Sustiva: 13 people, 24.53%
  7. Norvir: 12 people, 22.64%
  8. Retrovir: 9 people, 16.98%
  9. Viread: 9 people, 16.98%
  10. Viracept: 9 people, 16.98%

What are other side effects people have besides Lipodystrophy acquired? *

  1. High Blood Cholesterol: 16 people, 30.19%
  2. Weight Decreased: 8 people, 15.09%
  3. Sinusitis (inflammation of sinus): 8 people, 15.09%
  4. Diarrhea: 7 people, 13.21%
  5. Blood Creatine Phosphokinase Increased: 7 people, 13.21%
  6. Depression: 7 people, 13.21%
  7. Anaemia (lack of blood): 6 people, 11.32%
  8. Headache (pain in head): 6 people, 11.32%
  9. Hypertriglyceridaemia (excess of triglycerides in the blood): 5 people, 9.43%
  10. Back Pain: 5 people, 9.43%

What are the existing conditions these people have? *

  1. Hiv Infection: 23 people, 43.40%
  2. Oedema Peripheral (superficial swelling): 6 people, 11.32%
  3. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 6 people, 11.32%
  4. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 6 people, 11.32%
  5. Diabetes: 3 people, 5.66%
  6. Septic Rash (rash due to blood infection): 2 people, 3.77%
  7. Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 3.77%
  8. High Blood Pressure: 2 people, 3.77%
  9. Depression: 2 people, 3.77%
  10. Urinary Retention (the inability to completely or partially empty the bladder): 1 person, 1.89%

* Approximation only. Some reports may have incomplete information.

Do you take Bactrim and have Lipodystrophy acquired?

- Check whether Lipodystrophy acquired is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bactrim:

Lipodystrophy acquired treatments and more:

How severe was Lipodystrophy acquired and when was it recovered:

Expand to all the drugs that have ingredients of sulfamethoxazole; trimethoprim:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bactrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lipodystrophy acquired:

Browse all the conditions that are associated with Lipodystrophy acquired:


How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim (the active ingredients of Bactrim) and Bactrim (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: